Department of Laboratory Medicine, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
Division of Biosciences, Department of Structural & Molecular Biology, University College London, London, UK.
Biometals. 2019 Apr;32(2):211-226. doi: 10.1007/s10534-019-00183-7. Epub 2019 Feb 26.
In patients with iron overload disorders, increasing number of reports of renal dysfunction and renal iron deposition support an association between increased iron exposure and renal injury. In systemic iron overload, elevated circulating levels of transferrin-bound (TBI) and non-transferrin-bound iron (NTBI) are filtered to the renal proximal tubules, where they may cause injury. However, the mechanisms of tubular iron handling remain elusive. To unravel molecular renal proximal tubular NTBI and TBI handling, human conditionally immortalized proximal tubular epithelial cells (ciPTECs) were incubated with Fe as NTBI and fluorescently labeled holo-transferrin as TBI. Ferrous iron importers ZIP8 and ZIP14 were localized in the ciPTEC plasma membrane. Whereas silencing of either ZIP8 or ZIP14 alone did not affect Fe uptake, combined silencing significantly reduced Fe uptake compared to control (p < 0.05). Furthermore, transferrin receptor 1 (TfR1) and ZIP14, but not ZIP8, colocalized with early endosome antigen 1 (EEA1). TfR1 and ZIP14 also colocalized with uptake of fluorescently labeled transferrin. Furthermore, ZIP14 silencing decreased Fe uptake after Fe-Transferrin exposure (p < 0.05), suggesting ZIP14 could be involved in early endosomal transport of TBI-derived iron into the cytosol. Our data suggest that human proximal tubular epithelial cells take up TBI and NTBI, where ZIP8 and ZIP14 are both involved in NTBI uptake, but ZIP14, not ZIP8, mediates TBI-derived iron uptake. This knowledge provides more insights in the mechanisms of renal iron handling and suggests that ZIP8 and ZIP14 could be potential targets for limiting renal iron reabsorption and enhancing urinary iron excretion in systemic iron overload disorders.
在铁过载疾病患者中,越来越多的肾功能障碍和肾铁沉积的报告支持铁暴露增加与肾损伤之间存在关联。在系统性铁过载中,循环中升高的转铁蛋白结合铁 (TBI) 和非转铁蛋白结合铁 (NTBI) 被滤过到肾近端小管,在那里它们可能导致损伤。然而,肾小管铁处理的机制仍不清楚。为了阐明分子肾近端小管 NTBI 和 TBI 处理,用人条件性永生化近端肾小管上皮细胞 (ciPTEC) 孵育 Fe 作为 NTBI 和荧光标记的完整转铁蛋白作为 TBI。亚铁离子转运蛋白 ZIP8 和 ZIP14 定位于 ciPTEC 质膜上。尽管单独沉默 ZIP8 或 ZIP14 本身并不影响 Fe 摄取,但与对照相比,联合沉默显著降低了 Fe 摄取 (p<0.05)。此外,转铁蛋白受体 1 (TfR1) 和 ZIP14,但不是 ZIP8,与早期内体抗原 1 (EEA1) 共定位。TfR1 和 ZIP14 也与荧光标记转铁蛋白的摄取共定位。此外,ZIP14 沉默减少了 Fe-Transferrin 暴露后的 Fe 摄取 (p<0.05),这表明 ZIP14 可能参与 TBI 衍生铁向细胞质的早期内体转运。我们的数据表明,人近端肾小管上皮细胞摄取 TBI 和 NTBI,其中 ZIP8 和 ZIP14 均参与 NTBI 的摄取,但 ZIP14 而不是 ZIP8 介导 TBI 衍生铁的摄取。这一知识为肾脏铁处理的机制提供了更多的见解,并表明 ZIP8 和 ZIP14 可能是限制系统性铁过载疾病中肾铁重吸收和增加尿铁排泄的潜在靶点。